CJC-1295 w/ DAC 5mg – Long-Acting Research Peptide

Extended-release peptide engineered for sustained growth hormone pathway research.

CJC-1295 with DAC (Drug Affinity Complex) is a modified GHRH analog designed for prolonged activity and enhanced stability in research environments. The addition of DAC allows for extended circulation time, making it a key compound in studies focused on long-duration signaling and sustained endocrine response.

Our CJC-1295 w/ DAC 5mg is produced under strict quality control standards, ensuring exceptional purity, consistency, and reliability for advanced research applications.

Product Details

• Compound: CJC-1295 w/ DAC

• Quantity: 5mg per vial

• Purity: ≥99% (HPLC tested)

• Appearance: Lyophilized white powder

• Storage: Store in a cool, dry place (refrigeration recommended after reconstitution)

  
  

Key Research Areas

• Sustained growth hormone signaling pathways

• Extended peptide half-life and stability studies

• Endocrine system modulation over time

• IGF-1 pathway and long-duration response models

  
  

What Makes DAC Different

• Significantly extended half-life compared to non-DAC versions

• Prolonged receptor interaction and signaling duration

• Reduced frequency requirements in long-term study designs

  
  

Why Choose Biozone

• Precision-manufactured for consistent research outcomes

• Third-party tested for purity and identity

• Sterile, sealed vials for maximum integrity

• Trusted by researchers focused on long-acting peptide systems

  
  

Important Notice

This product is intended for research purposes only. Not for human consumption, therapeutic, or diagnostic use.